Explore more topics
Public ownership evidence

Bolt Biotherapeutics, Inc. Common Stock (BOLT) Ownership Disclosures

Read BOLT insider transactions, institutional 13F filings and Congressional disclosures with report dates, public availability and original receipts.

As of 2026-11-07T14:03:26.246Z

Jump to a section

Read one actual disclosure before using it

Show the table · 1 row, 6 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-10-272026-10-23GUJRATHI SHEILAA13,055Not reported

First displayed source row from Recent Form 4 activity. The full bounded history and coverage notes remain below.

The displayed observation date is 2026-10-23 and its public availability date is 2026-10-27. Subtracting those calendar dates gives 4 days of disclosure lag. Historical public research can use the record from the availability date, rather than backdating knowledge to the observation date. The calendar-day difference does not assert an intraday publication time.

This row is code A: a award. An award is an acquisition but is not an open-market purchase. A purchase-following rule must not count it as code P.

Open the linked original receipts to verify the row, then inspect a second record before drawing a pattern. This public filing observation supplies source evidence, not a completed copy-trading return.

SEC 0001193125-26-434468 ↗SEC 0001193125-26-434468 ↗SEC 0001193125-26-396894 ↗

Recent Form 4 activity

Inspect all 13 displayed rows: Recent Form 4 activity

Scroll sideways to compare all columns. Select a heading to sort.

2026-10-272026-10-23GUJRATHI SHEILAA13,055Not reported
2026-10-272026-10-23GUJRATHI SHEILAA72,766Not reported
2026-09-212026-09-18Yonehiro GrantS6,850Not reported
2026-09-212026-09-17Yonehiro GrantS4,909Not reported
2026-09-212026-09-16Yonehiro GrantS1,417Not reported
2026-09-212026-09-18Nemec SarahS4,077Not reported
2026-09-212026-09-17Nemec SarahS2,922Not reported
2026-09-212026-09-16Nemec SarahS843Not reported
2026-09-212026-06-05Nemec SarahP509Not reported
2026-09-212026-09-18Quinn William P.S9,132Not reported
2026-09-212026-09-17Quinn William P.S6,545Not reported
2026-09-212026-09-16Quinn William P.S1,889Not reported
2026-09-212026-06-05Quinn William P.P637Not reported

90-day public availability window, up to 50 records.

Recent institutional filing receipts

Inspect all 24 displayed rows: Recent institutional filing receipts

These are raw ticker-matched positions in recent 13F receipts, including amendments. They are not deduplicated current ownership totals. Open the manager profile to inspect its effective filing book.

Scroll sideways to compare all columns. Select a heading to sort.

Shay Capital LLC2026-06-302026-08-1515,438$59,436None
NANO CAP NEW MILLENNIUM GROWTH FUND L P2026-06-302026-08-1527,500$105,875None
Vivo Capital, LLC2026-06-302026-08-1572,414$278,794None
CITADEL ADVISORS LLC2026-06-302026-08-1556,903$219,077None
Sofinnova Investments, Inc.2026-06-302026-08-15137,721$530,226None
BARCLAYS PLC2026-06-302026-08-156$23None
VANGUARD CAPITAL MANAGEMENT LLC2026-06-302026-08-147,060$27,181None
Lynx1 Capital Management LP2026-06-302026-08-1430,800$118,580None
UBS Group AG2026-06-302026-08-14253$974None
UBS Group AG2026-06-302026-08-142$8None
RENAISSANCE TECHNOLOGIES LLC2026-06-302026-08-1498,625$379,706None
Nan Fung Group Holdings Ltd2026-06-302026-08-145,000$19,250None
VANGUARD FIDUCIARY TRUST CO2026-06-302026-08-143,095$11,916None
MORGAN STANLEY2026-06-302026-08-1417$65None
MORGAN STANLEY2026-06-302026-08-143,128$12,043None
Pfizer Inc2026-06-302026-08-1431,305$133,832None
Lynx1 Capital Management LP2026-06-302026-08-1330,800$118,580None
GEODE CAPITAL MANAGEMENT, LLC2026-06-302026-08-134,557$17,544None
GEODE CAPITAL MANAGEMENT, LLC2026-06-302026-08-1314,562$56,078None
NewEdge Advisors, LLC2026-06-302026-08-132,530$9,740None
Board of Trustees of The Leland Stanford Junior University2026-06-302026-08-1335,977$138,511None
JPMORGAN CHASE & CO2026-06-302026-08-1342$165None
Tower Research Capital LLC (TRC)2026-06-302026-08-121,710$6,584None
MERCER GLOBAL ADVISORS INC /ADV2026-06-302026-08-12292$1,124None

90-day public filing window, up to 50 source positions.

Shay Capital LLC ↗NANO CAP NEW MILLENNIUM GROWTH FUND L P ↗Vivo Capital, LLC ↗CITADEL ADVISORS LLC ↗Sofinnova Investments, Inc. ↗BARCLAYS PLC ↗VANGUARD CAPITAL MANAGEMENT LLC ↗Lynx1 Capital Management LP ↗UBS Group AG ↗UBS Group AG ↗

Recent Congressional disclosures

No matching Congressional transactions were returned in this source preview.

Show the table · 0 rows, 5 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Bounded public source preview, up to 25 disclosed events.

How to read the disclosure dates

The tables report different things: insider transactions, institutional positions and Congressional transaction ranges. Read each table with its source dates and units. They cannot be added into a combined ownership percentage.

  1. Company insiders

    SEC Form 4 purchases, sales and awards report transactions and their public filing availability.

  2. Institutional managers

    13F reports disclose delayed quarter-end positions. They are not a record of trades between quarters.

  3. Congressional filers

    Periodic transaction reports disclose transaction dates and amount brackets. Public filing dates determine what researchers could know.

Institutional source directory ↗Congressional source directory ↗

Read the transaction codes

Awards use transaction code A, purchases P and sales S. An acquisition from an award is not the same as an open-market purchase. Joint filers may share a transaction. Use original receipts and availability dates to interpret the events.